GLP Watchdog
GOAL.MD logo

GOAL.MD Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.9/10

Best for: starting below a standard dose, with microdose tiers

7.9
★★★★☆4/5

GOAL.MD's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.

$179/mo
Same price at every dose

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

GOAL.MD is a St. Louis-based telehealth platform. Compounded semaglutide starts at $179/mo, brand Ozempic and Wegovy from $294/mo, and Zepbound from $394/mo, with brand pen pricing published by dose tier and offered as a bridge to the brand drugs. Renewals are manual with no auto-billing, and a nutrition coach is included free.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $179/moPrice shown up frontFlat across dosesIncludes medication + consultAll 50 statesNo FDA letter on record

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Vetted alternatives to GOAL.MD

7.9/ 10
Verified partner

Oak

Best for: semaglutide at $119/month, 37% under the register median

★★★★☆4/5

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →
6.5/ 10
Verified partner

Direct Meds

Best for: compounded semaglutide at $249/month

★★★☆☆3.3/5

Editorial score · methodology

$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
8.8/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% under the register median

★★★★☆4.4/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
GOAL.MD logo
4.0 / 5
Our editorial rating
Visit GOAL.MD →

from $179/mo · no insurance needed

GOAL.MD at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Wegovy, Ozempic, Zepbound
Starting price
$179/mo
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping · Coaching
Availability
All 50 states
FDA status
No FDA warning letter on record

How GOAL.MD scores

Six columns, each one computed from something GOAL.MD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.

Value25%

5.4/10

$179/month is 5% below the register median of $189 for compounded semaglutide.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

8.0/10

On the seller's own pages, a price is published before the questionnaire starts.

Trust & Safety15%

6.5/10

does not name a dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is low.

Accessibility10%

10.0/10

Publishes coverage in 50 of 50 states.

Support10%

8.5/10

The price covers medication, consult, shipping, coaching.

6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →

What we checked on GOAL.MD

Last checked July 2026
  • Re-read the price on file across 9 dose or plan tiers
  • Checked state coverage: all 50
  • Established what the monthly figure covers, and what it leaves out
  • Searched our FDA enforcement register for this operator

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: low.

What signing up with GOAL.MD involves

Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.

  1. 1GOAL.MD publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
  2. 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
  3. 3GOAL.MD does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
  4. 4The monthly price is recorded as covering medication, consult, shipping, coaching.
Price shown before you start
  • Cheapest standing monthly prices on record: semaglutide $179, a GLP-1 $294. Membership fees, first-month rates and insured copays are excluded from those figures.
  • Coverage is published for all 50 states.
  • The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.

GOAL.MD support, as documented

Phone
800.674.2855
Email
customer@jellyfish.md
Hours
M-F 9am-5pm Central

GLP-1 medications GOAL.MD offers

Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.

SemaglutideTirzepatideWegovyOzempicMounjaroZepboundRybelsus

Pricing

Prices re-verified

Personalized (compounded, all doses)Compounded
$179/mo
semaglutide
Micro-Dose (compounded)Compounded
$197/mo
semaglutide
Oral pillBrand-name
$244/mo
semaglutide
0.25-0.5 mg penBrand-name
$294/mo
ozempic
1 mg penBrand-name
$444/mo
ozempic
2 mg penBrand-name
$594/mo
ozempic
Pen (starter)Brand-name
$294/mo
wegovy
Vial / KwikPenBrand-name
$394/mo
zepbound
StartingCompounded
$249/mo
tirzepatide

Personalized (compounded) tirzepatide from $249/mo new-patient first month; brand Zepbound from $394/mo

Check the price yourself before you pay

Every figure here was read off GOAL.MD's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See GOAL.MD pricing →

In its favor

  • Tirzepatide at $394 a month, 68% below the $1249 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping, coaching
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Against it

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What GOAL.MD charges

GOAL.MD charges $179/month, and holds that rate across every dose. Flat dose pricing matters more than it reads: on a tiered plan the bill grows as the dose does, which means the figure that persuaded you to sign up is not the figure you end up living with.

  • Compounded semaglutide — $179/month
  • Compounded semaglutide — $197/month
  • Brand-name semaglutide — $244/month
  • Brand-name ozempic — $294/month
  • Brand-name ozempic — $444/month
  • Brand-name ozempic — $594/month

The median across the GLP-1 providers we track is about $169/month, so this lands mid-market — close enough that the deciding factor is unlikely to be price.

Found dispenses semaglutide and tirzepatide from $149/month, which makes it the honest comparison to run before committing here.

What GOAL.MD dispenses

GOAL.MD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade.

What we could verify

On the record: it treats patients in all 50 states and coaching is included rather than sold on top. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.

Who should look elsewhere

  • You need to bill insurance. Like most of this market, this is cash-pay.

It fits if

  • you want the price to stop moving as your dose climbs
  • you want coaching bundled rather than metered
  • you need access regardless of where you live

Our read

GOAL.MD lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits. Breeze Meds is the nearest comparison we track, and worth reading alongside this.

The Bottom Line

GOAL.MD's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.

Score: 7.9/10Best for: starting below a standard dose, with microdose tiersFrom: $179/mo

Before you pay GOAL.MD

Starting at $179/month. Check today's price, then book the free consultation.

Visit GOAL.MD →
See all alternatives to GOAL.MD →

Frequently Asked Questions

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this GOAL.MD review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of August 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See GOAL.MD's current pricing

Plans start at $179/month. The free consultation is where you learn whether you qualify, and what it costs today.

Visit GOAL.MD →